Improving recovery after surgery for neurocritical care patients
A Randomized Controlled Clinical Study on Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care Patients
This study tests a new recovery plan for patients in neurocritical care after surgery to see if it helps them heal faster and have fewer complications compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Shanghai 6th People's Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Trial ID | NCT06241482 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety and efficacy of an Enhanced Recovery After Surgery (ERAS) protocol specifically designed for patients in neurocritical care, including those with traumatic brain injury and cerebrovascular disease. The ERAS approach focuses on optimizing perioperative management to reduce complications, promote faster recovery, and decrease hospital stays. By implementing evidence-based practices, the study aims to enhance patient outcomes in neurosurgical intensive care settings. The research will compare the ERAS protocol to conventional therapy to assess its effectiveness.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-75 with moderate to severe acute traumatic brain injury or cerebrovascular disease requiring intensive care.
Not a fit: Patients undergoing non-surgical treatment or those diagnosed as brain dead shortly after admission will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery times and outcomes for patients undergoing neurosurgery.
How similar studies have performed: While ERAS has been successful in various surgical fields, its application in neurosurgery is relatively novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-75 years old * Patients with moderate or severe acute traumatic brain injury or cerebrovascular disease requiring neurosurgical intensive care treatment * Hospitalization time ≥ 1 week * The guardian is able to understand and actively cooperate in completing the project * The guardian signs an informed consent form Exclusion Criteria: * Patients undergoing non-surgical treatment * Patients diagnosed as brain death within the first 24 hours after admission to NICU * Patients undergoing cardiopulmonary resuscitation, maintenance dialysis, end-stage tumors, and disseminated cancer * Patients who withdraw treatment during hospitalization or are discharged automatically * Patients who underwent unplanned secondary surgery during the research process * Individuals who cannot be followed up during the research process
Where this trial is running
Shanghai
- Shanghai 6th People's Hospital — Shanghai, China (Recruiting)
Study contacts
- Study coordinator: Hao Chen, M.D., Ph.D.
- Email: hao.chen@shsmu.edu.cn
- Phone: 8602164369181
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.